Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited’s Net Profit Rose 3.8% in First Half of 2022

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (广州白云山医药集团股份有限公司) (600332.SH) reported a net profit of 2.7 billion yuan in the first half of 2022, up 3.8% year-on-year.

Meanwhile, the company posted 37.2 billion yuan in revenue, up 3% year-on-year.

At the end of the reporting period, it had 66.8 billion yuan in total assets and 33.8 billion yuan in total liabilities, with a liability-to-asset ratio of 50.7%.